Alalem, M.; Bhosale, M.; Ranjan, A.; Yamamoto, S.; Kaida, A.; Nishikawa, S.; Parrales, A.; Farooki, S.; Anant, S.; Padhye, S.;
et al. Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin. Cancers 2022, 14, 4187.
https://doi.org/10.3390/cancers14174187
AMA Style
Alalem M, Bhosale M, Ranjan A, Yamamoto S, Kaida A, Nishikawa S, Parrales A, Farooki S, Anant S, Padhye S,
et al. Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin. Cancers. 2022; 14(17):4187.
https://doi.org/10.3390/cancers14174187
Chicago/Turabian Style
Alalem, Mohamed, Mrinalini Bhosale, Atul Ranjan, Satomi Yamamoto, Atsushi Kaida, Shigeto Nishikawa, Alejandro Parrales, Sana Farooki, Shrikant Anant, Subhash Padhye,
and et al. 2022. "Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin" Cancers 14, no. 17: 4187.
https://doi.org/10.3390/cancers14174187
APA Style
Alalem, M., Bhosale, M., Ranjan, A., Yamamoto, S., Kaida, A., Nishikawa, S., Parrales, A., Farooki, S., Anant, S., Padhye, S., & Iwakuma, T.
(2022). Mutant p53 Depletion by Novel Inhibitors for HSP40/J-Domain Proteins Derived from the Natural Compound Plumbagin. Cancers, 14(17), 4187.
https://doi.org/10.3390/cancers14174187